1. Lipoprotein lipase (EC 3.1.1.34), which was previously shown to bind to immobilized heparin, was now found to bind also to heparan sulphate and dermatan sulphate and to some extent to chondroitin sulphate. 2. The relative binding affinities were compared by determining (a) the concentration of NaCl required to release the enzyme from polysaccharide-substituted Sepharose; (b) the concentration of free polysaccharides required to displace the enzyme from immobilized polysaccharides; and (c) the total amounts of enzyme bound after saturation of immobilized polysaccharides. By each of these criteria heparin bound the enzyme most efficiently, followed by heparan sulphate and dermatan sulphate, which were more efficient than chondroitin sulphate. 3. Heparin fractions with high and low affinity for antithrombin, respectively, did not differ with regard to affinity for lipoprotein lipase. 4. Partially N-desulphated heparin (40-50% of N-unsubstituted glucosamine residues) was unable to displace lipoprotein lipase from immobilized heparin. This ability was restored by re-Nsulphation or by N-acetylation; the N-acetylated product was essentially devoid of anticoagulant activity. 5. Partial depolymerization of heparin led to a decrease in ability to displace lipoprotein lipase from heparin-Sepharose; however, even fragments of less than decasaccharide size showed definite enzyme-releasing activity. 6. Studies with hepatic lipase (purified from rat post-heparin plasma) gave results similar to those obtained with milk lipoprotein lipase. However, the interaction between the hepatic lipase and the glycosaminoglycans was weaker and was abolished at lower concentrations of NaCI. 7. The ability of the polysaccharides to release lipoprotein lipase to the circulating blood after intravenous injection into rats essentially conformed to their affinity for the enzyme as evaluated by the experiments in vitro.
While studying the anticoagulant effects of injected heparin, Hahn (1943) noted that heparin also caused the appearance in blood of a lipaemia 'clearing factor'. Korn (1955) showed that this factor is a lipolytic enzyme and was able to recover enzyme preparations with similar properties from several tissues. The enzyme was called lipoprotein lipase because of its high activity against the triacylglycerol of plasma lipoproteins. It was later found that lipoprotein lipase binds to heparin and this binding has been exploited for affinity purification (Olivecrona et al., 1971) . Under certain conditions heparin can increase the activity of crude enzyme preparations, but has no effect on purified lipoprotein lipase (Iverius et al., 1972) . More recently, a second lipase activity was demonstrated in post-heparin plasma; it probably originates in the liver and is usually referred to as hepatic lipase (La Rosa et al., 1972) . This lipase also binds to heparin (Hemell et al., 1975) . Although the ability to bind heparin seems to be a general property of these lipases it is not known what molecule, if any, occupies the heparin-binding site in vivo. The present study demonstrates that the lipases bind also to other sulphated polysaccharides, such as heparan sulphate and dermatan sulphate. The structural features required for binding of various glycosaminoglycans, particularly heparin, to lipoprotein lipase have been studied in some detail.
Experimental Preparation and assay oflipases
Lipoprotein lipase was purified from bovine milk as described . Hepatic lipase was obtained from post-heparin plasma of rats injected 7min earlier with 1 mg of heparin/kg body wt. It was partially purified by chromatography on heparin-Sepharose (Hernell et al., 1975) .
Lipase activities were measured as described (Hernell et al., 1975) at pH 8.5 with [3Hloleic acid-labelled trioleoylglycerol emulsified in gum arabic as substrate. Lipoprotein lipase was assayed in 0.1 M-NaCl with human serum added as source of activator; hepatic lipase was assayed in 1 M-NaCI in the absence of serum. One unit of lipase is defined as the amount of enzyme that releases one ,mol of fatty acid/min at 370C.
Glycosaminoglycans
Analytical data for the polysaccharide preparations are given in Table 1 . Heparin (stage 14) isolated from pig intestinal mucosa was purchased from Inolex Pharmaceutical Division, Park Forest South, IL, U.S.A. and was purified by precipitation with cetylpyridinium chloride from 1.2 M-NaCI (Lindahl et al., 1965) .
Fractionation of heparin with regard to its affinity for antithrombin was carried out by affinity chromatography on antithrombin-Sepharose (Laurent et al., 1978) .
Partial N-desulphation of heparin was achieved by treating the polysaccharide with 0.04 M-HCI at 500 C for varying periods of time (Riesenfeld et al., 1977) . In some experiments the amino groups exposed during previous N-desulphation were acetylated by treatment with acetic anhydride (Danishefsky & Steiner, 1965) or resulphated by treatment with trimethylamine-SO3 complex (Levy & Petracek, 1962) .
To prepare heparin fragments differing with regard to molecular size, 50mg of heparin was treated with nitrous acid (reaction A in Lindahl et al., 1973) (Jansson et al., 1975) , were 3800, 3000 and 2100, respectively, in fair agreement with the values obtained by gel chromatography (assuming a molecular weight for a heparin disaccharide unit of about 600).
Heparan sulphate was prepared from human aorta, as described by Iverius (1971) . Analysis of the final product by ion-exchange chromatography showed a low-sulphated material without any detectable heparin-like components.
Dermatan sulphate, prepared by alkaline copper precipitation from heparin by-products, was a gift from Mrs. Kajsa Roden, University of Alabama, Birmingham, AL, U.S.A., and was further purified as described (Teien et al., 1976) .
Chondroitin 4-sulphate from bovine nasal cartilage was kindly donated by Dr. A. Wasteson, University of Uppsala, Sweden.
Glycosaminoglycan-substituted agarose gels
Most gels were prepared according to Iverius (1971) ; 2mg of polysaccharide was added/ml of CNBr-activated Sepharose (Pharmacia, Uppsala, Sweden). Heparin-Sepharose gels with a lower degree of substitution (designated 1/10 and 1/50 heparin-Sepharose) were prepared by adding 0.2 mg and 0.04mg of heparin/ml of activated Sepharose, respectively. Some substituted gels were prepared by mixing polysaccharide, non-activated Sepharose 4B and CNBr under the conditions described by Miller-Andersson et al. (1974) . Glycosaminoglycan-substituted Sepharose gels were used for one experiment only and were then discarded. The amounts of polysaccharide bound/ml of gel are indicated in the legends to the Figures.
Studies ofenzyme-glycosaminoglycan interaction in vitro
Equilibration experiments. An enzyme solution was equilibrated with a small volume of polysaccharide-substituted gel for at least 30min under the conditions described in detail in the legend to Table 2 . Bovine serum albumin (1%, w/v) was added to increase the stability of the enzyme and to decrease non-specific binding to the gel of polysaccharide-substituted Sepharose (0.1-0.3 mg of ligand/ml of gel). After passage of a total of 440 units of lipoprotein lipase through the columns the enzyme activity in the effluents exceeded 90% of that of the solutions applied. The columns were then eluted with 10ml of 1.5 M-NaCl in the same buffer, and the enzyme activity of the eluate was determined.
Experiments in vivo
To assess the ability of the native or modified glycosaminoglycans to release lipases in vivo, the polysaccharides were injected intravenously into rats. After 7min, blood was withdrawn from the exposed abdominal aorta. Plasma was prepared and was analysed for lipoprotein lipase and for hepatic lipase, either directly or after separation of the two enzymes by chromatography on heparin-Sepharose .
Results

Interaction in vitro between lipoprotein lipase and glycosaminoglycans
Lipoprotein lipase was virtually quantitatively adsorbed to heparin-Sepharose at 0.32M-NaCl. On increasing the ionic strength of the incubation medium, no significant release of enzyme occurred at lower concentrations of NaCl than 0.6M; complete liberation of the enzyme required about 1.0 M-NaCl. At 0.88 M-NaCl 50% of the enzyme was in solution (Table 2 ). Both heparan sulphateSepharose and dermatan sulphate-Sepharose bound more than 85% of the enzyme at 0.32M-NaCl, but the enzyme was released at lower salt concentrations from these gels than from the heparinSepharose ( Table 2 ). The chondroitin sulphateSepharose bould less than 50% of the enzyme at 0.32 M-NaCl (Table 2) ; furthermore the adsorbed enzyme was released by a very moderate increase in ionic strength. No experiments were carried out at lower concentrations of NaCl than 0.32M, owing to the limited stability and solubility of the enzyme under these conditions. Table 3 summarizes experiments in which free and immobilized polysaccharide molecules were allowed to compete for the lipoprotein lipase Table 2 . Displacement oflipasesfrom glycosaminoglycan-substituted Sepharose on addition ofNaCI to the liquid phase Enzyme (about 12pg of lipoprotein lipase or equivalent activity of the partially purified hepatic lipase) was equilibrated with 0.1 ml of the respective gels in a total volume of 1 ml of 5 mM-sodium veronal buffer, pH 7.4, containing 0.32M-NaCI and 1% bovine serum albumin. After 1 h at 40C with gentle agitation the tubes were centrifuged at 2000g for 2 min and samples of the supernatants were removed for assay of enzyme activity. After appropriate additions of S M-NaCl the contents of the tubes were mixed and incubated for 20 min as above. Centrifugation, sampling of the supernatants and further additions of NaCI (stepwise concentration increments of 0.1 M up to 1.0 M-NaCI) were repeated in the same manner, such that all data for one type of gel were obtained from the same tube. Role of the N-substituent. Heparin was partially N-desulphated by treatment with 0.04 M-HCl at 50°C for various periods of time. The material obtained after 8 h of hydrolysis showed a low but significant ability to displace lipoprotein lipase from immobilized heparin, but after 16 h of hydrolysis this ability was completely lost (Fig. 1) . The latter sample retained about half of the initial N-sulphate groups (Table 1) . After re-N-sulphation this material displaced lipoprotein lipase as efficiently as did the starting material. However, also N-acetylation restored full ability to release the enzyme (Fig. 1) . Saturation experiments showed no significant difference in enzyme-binding capacity between gels substituted with the partially N-desulphated, Nacetylated heparin and with the heparin starting material, respectively. However, a somewhat lower salt concentration was required to displace the enzyme from the modified material than from the native heparin (Table 2) . This may reflect a lower affinity of the modified heparin for the enzyme.
Role of molecular size. Heparin fragments of various molecular sizes were added to samples of lipoprotein lipase, bound to unmodified, immobilized heparin (Fig. 2) . The ability of the fragments to displace the enzyme decreased continuously with Vol. 189 [Polysaccharidel (ug/ml) Fig. 1 . Displacement of lipoprotein lipase from heparinSepharose by partially N-desulphated heparin before and after N-acetylation or re-N-sulphation The conditions were as described in Relation to heparin-antithrombin interaction. Separation of heparin by affinity chromatography on matrix-bound antithrombin yields two distinct fractions, one with low affinity for antithrombin and very low anticoagulant activity, and one with high affinity for antithrombin and high anticoagulant activity (see Lindahl et al., 1979 , for references). The two fractions could not be distinguished by chromatography on immobilized lipoprotein lipase, and showed equal ability to displace lipoprotein lipase from immobilized (unfractionated) heparin . These results suggested that the heparin molecule contains different binding sites for antithrombin and for lipoprotein lipase. This conclusion is supported by the results obtained in the present study, showing that the same NaCl concentration is required to displace lipoprotein lipase from immobilized heparins having high and low affinity for antithrombin, respectively (Table 2) .
Interaction in vitro between hepatic (heparin-releasable) lipase and glycosaminoglycans Experiments analogous to those described above for lipoprotein lipase were also carried out with hepatic lipase partially purified from rat post-heparin plasma. In equilibration experiments this lipase bound to Sepharose gels substituted with either heparin, heparin fractions separated with regard to affinity for antithrombin, partially N-desulphated and N-acetylated heparin or heparan sulphate. The various polysaccharides showed the same relative affinities for hepatic lipase as for lipoprotein lipase, as judged from salt-displacement experiments (Table  2) . However, the salt concentration required to displace the hepatic lipase was always lower than for lipoprotein lipase, suggesting a lower affinity of the hepatic lipase for these polysaccharides. The difference was quite large; for instance, 50% displacement of enzyme activity from a heparin-substituted Sepharose gel occurred at 0.45 M-NaCl for the hepatic lipase but at 0.88M-NaCl for lipoprotein lipase. As with lipoprotein lipase ) the salt-displacement properties of the hepatic lipase depended on the nature of the salt and on the degree of polysaccharide substitution of the gel. Table 4 . Release oflipases into the circulating blood by intravenous injection ofpolysaccharide preparations The determination of salt-resistant lipase (considered to represent hepatic lipase) and serum-stimulated lipase (lipoprotein lipase) was as described in a previous paper The displacement of hepatic lipase from heparinor heparan sulphate-substituted Sepharose on the addition of various competing polysaccharides to the liquid phase was also studied. The results of these experiments were qualitatively similar to those obtained with lipoprotein lipase. Thus, heparin subfractions with high affinity and low affinity for antithrombin, respectively, were equally efficient in displacing the hepatic lipase. Furthermore, the enzyme-displacing ability was lost by partial Ndesulphation of heparin (16h hydrolysis) and was restored either by re-N-sulphation or by N-acetylation of the polysaccharide.
Studies in vivo
The ability to release lipoprotein lipase and hepatic lipase from their tissue sites to the circulating blood was tested by intravenous administration of the various glycosaminoglycans to rats. About 0.5 mg of hepaTin/kg body weight is required to induce half-maximal release of either enzyme . When other polysaccharides were injected in amounts of 1.5 or 3mg, a comparable release of lipases occurred only with the partially N-desulphated and then N-acetylated heparin (Table 4) . The partially N-desulphated heparin (16h hydrolysis), the heparan sulphate and the dermatan sulphate caused a small but significant release of both lipases, whereas chondroitin sulphate was essentially inactive. No attempt was made to rank the relatively inactive polysaccharides by injecting larger amounts of these materials.
Discussion
Previous studies have established that heparin binds strongly and reversibly to lipoprotein lipase . The present study demonstrates that heparin is not the only polysaccharide that can bind lipoprotein lipase; this property is shared also by heparan sulphate and dermatan sulphate, and to a lesser extent, by chondroitin sulphate. However, in all experimental systems tested, the interaction of lipoprotein lipase with these polysaccharides was weaker than that with heparin. No attempt was made to differentiate between heparan sulphate and dermatan sulphate with regard to enzyme affinity; in fact, such attempts appear less meaningful in view of the extensive structural variability of these species (Lindahl & H66k, 1978) .
Some observations regarding the structural features of polysaccharides that bind to lipoprotein lipase may be considered. Heparin, heparan sulphate and dermatan sulphate all have higher affinities for lipoprotein lipase than has chondroitin sulphate. This difference in affinity cannot simply be ascribed to the degree of polyanion character, as the heparan sulphate preparation used had a lower sulphate content and yet a higher affinity for the enzyme than had the chondroitin sulphate. The common structural denominator for the three effective polysaccharides is the presence of L-iduronic acid (which is not present in chrondroitin sulphate); it therefore seems likely that this component is somehow important for the binding of polysaccharides to lipoprotein lipase (see Lindahl & Hook, 1978 , for similar conclusions regarding interactions with other proteins, such as collagen and platelet factor 4). The hexosamine units should be Nsubstituted, since partial N-desulphation led to loss of enzyme-binding ability; apparently, free amino groups impede the interaction. However, the exact nature of this requirement is unclear. N-Sulphate groups are obviously not essential for enzyme binding, as seen from the binding properties of Vol. 189 dermatan sulphate (which contains exclusively Nacetylated hexosamine residues). Furthermore, a major fraction of the N-sulphate groups in heparin could be replaced by N-acetyl groups without appreciable loss of enzyme affinity. On the other hand, it is not known to what extent the remaining N-sulphate groups contributed to the high enzyme affinity of the heparin derivative. In a more recent experiment, N-acetylation of a completely N-desulphated heparin (obtained by treatment with aqueous dimethylsulphoxide; Inoue & Nagasawa, 1976) failed to restore the affinity for lipoprotein lipase (G. Bengtsson, T. Olivecrona, M. Ho6k, J. Riesenfeld & U. Lindahl, unpublished work). To elucidate fully the role of N-sulphate groups, graded Ndesulphation should be performed, yielding a series of heparin derivatives with continuously varied N-sulphate/N-acetyl ratios.
The hepatic lipase has many properties in common with lipoprotein lipase. It hydrolyses the same substrates (Ehnholm et al., 1974 (Ehnholm et al., , 1975 , shows the same positional specificity in hydrolysis of triacylglycerols (Akesson et al., 1976) , and has a similar monomer molecular size (tfstlund-Lindqvist & Boberg, 1977) . Kinetic differences can be used to differentiate the two enzymes; in contrast with lipoprotein lipase, the activity of the hepatic lipase is not stimulated by apolipoprotein CII and is not strongly inhibited by 1 M-NaCl (La Rosa et al., 1972; Greten et al., 1972) . The hepatic lipase, previously known to bind to heparin-Sepharose (Greten et al., 1972; Hernell et al., 1975) , was now found to bind to the same modified heparins and other polysaccharides as did lipoprotein lipase. However, the binding was always weaker with the hepatic lipase, indicating a lower affinity; the hepatic lipase was thus displaced from gel-bound polysaccharides at lower salt concentrations than was lipoprotein lipase. In all experimental systems tested, the various polysaccharides showed essentially the same relative affinities for hepatic lipase as for lipoprotein lipase. Although the binding of hepatic lipase is weaker than that of lipoprotein lipase, these results suggest that the same requirements regarding polysaccharide structure apply to the binding of either enzyme. It is of interest to note that whereas the hepatic lipase is monomeric (Ehnholm et al., 1974) , the lipoprotein lipase used here is dimeric (Iverius & Ostlund-Lindqvist, 1976) (Olivecrona & Bengtsson, 1978) . With antithrombin the situation is different, since binding of heparin to this protein depends strictly on the presence of variously substituted monosaccharide units, without any apparent relation to charge density . Heparin molecules that lack this particular binding sequence (and thus have low affinity for antithrombin) still interact strongly with lipoprotein lipase. There is no indication of the involvement of any similar or analogous binding site in the heparinlipase interaction. This difference is clearly illustrated by the effects of N-desulphation. Partial N-desulphation of heparin leads to partial loss of anticoagulant activity that cannot be restored by acetylation of the exposed free amino groups (Nagasawa et al., 1977) , and recent studies indicate a stringent requirement for N-sulphate groups in certain positions of the antithrombin-binding sequence (J. Riesenfeld, M. Hook & U. Lindahl, unpublished work). In contrast, lipase binding was abolished by partial N-desulphation but was then restored by subsequent N-acetylation. As expected, the resulting modified polysaccharide was essentially devoid of anticoagulant activity (Table 1) . It is thus possible to prepare heparin derivatives that have low affinity for antithrombin but high affinity for lipoprotein lipase. Such preparations have been successfully used as affinity matrices for the chromatographic separation of lipoprotein lipase and antithrombin (G. Bengtsson & T. Olivecrona, unpublished work) .
Chromatography of heparin on immobilized lipoprotein lipase affords subfractions that differ with regard to affinity for this enzyme (Olivecrona & Bengtsson, 1978) . The affinity of these subfractions for antithrombin has not been studied. A possibility that remains to be explored is the preparation of heparin fractions (or derivatives) with high affinity for antithrombin and low affinity for the lipases.
